Upstream Bio
At Upstream Bio we strive to reach the source of inflammation and conquer it. We are leveraging our diverse roots and the team's substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones.
1
Funding Rounds
$200.0m
Money raised
Overview
At Upstream Bio we strive to reach the source of inflammation and conquer it. We are leveraging our diverse roots and the team's substantial industry experience to develop therapies that ease the burden of inflammatory and allergic diseases on patients and their loved ones.
Funding series
Funding Series Analysis
The company Upstream Bio has raised a total of $200m in funding over 1 rounds.
Key Insights:
- Upstream Bio Series A round, June 2022: $200m
Upstream Bio Series A round, June 2022
$200m
Industries
Upstream Bio is active in the following industries: